StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI – Free Report) from a hold rating to a buy rating in a research report released on Tuesday.
A number of other research firms also recently commented on ICUI. Raymond James set a $97.00 target price on ICU Medical in a report on Wednesday, March 12th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, ICU Medical currently has an average rating of “Buy” and an average price target of $168.67.
View Our Latest Research Report on ICU Medical
ICU Medical Stock Performance
Insider Transactions at ICU Medical
In other news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the transaction, the chief executive officer now owns 104,593 shares of the company’s stock, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 6.70% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Arizona State Retirement System raised its stake in shares of ICU Medical by 1.0% during the 4th quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock worth $1,044,000 after buying an additional 65 shares during the last quarter. Huntington National Bank raised its stake in ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 82 shares during the last quarter. Equitable Trust Co. raised its stake in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after purchasing an additional 84 shares during the last quarter. LPL Financial LLC raised its stake in ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after purchasing an additional 93 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in ICU Medical by 0.5% in the 4th quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock valued at $4,051,000 after purchasing an additional 136 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.
About ICU Medical
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
Read More
- Five stocks we like better than ICU Medical
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Must-Own Stocks to Build Wealth This Decade
- Conference Calls and Individual Investors
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.